dc.contributor.author |
Feldman, Kristyn E. |
|
dc.contributor.author |
Loriaux, Paul M. |
|
dc.contributor.author |
Saito, Mayuko |
|
dc.contributor.author |
Tuero Ochoa, Iskra |
|
dc.contributor.author |
Villaverde, Homarh |
|
dc.contributor.author |
Siva, Tenaya |
|
dc.contributor.author |
Gotuzzo Herencia, José Eduardo |
|
dc.contributor.author |
Gilman, Robert Hugh |
|
dc.contributor.author |
Hoffmann, Alexander |
|
dc.contributor.author |
Vinetz, Joseph Michael |
|
dc.date.accessioned |
2022-01-04T20:31:47Z |
|
dc.date.available |
2022-01-04T20:31:47Z |
|
dc.date.issued |
2013 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/10658 |
|
dc.description.abstract |
Brucellosis, a zoonotic infection caused by one of the Gram-negative intracellular bacteria of the Brucella genus, is an ongoing public health problem in Perú. While most patients who receive standard antibiotic treatment recover, 5–40% suffer a brucellosis relapse. In this study, we examined the ex vivo immune cytokine profiles of recovered patients with a history of acute and relapsing brucellosis. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Public Library of Science |
|
dc.relation.ispartofseries |
PLoS Neglected Tropical Diseases |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
gene expression |
en_US |
dc.subject |
Humans |
en_US |
dc.subject |
Peru |
en_US |
dc.subject |
controlled study |
en_US |
dc.subject |
innate immunity |
en_US |
dc.subject |
interleukin 4 |
en_US |
dc.subject |
interleukin 5 |
en_US |
dc.subject |
human cell |
en_US |
dc.subject |
real time polymerase chain reaction |
en_US |
dc.subject |
Real-Time Polymerase Chain Reaction |
en_US |
dc.subject |
cytokine |
en_US |
dc.subject |
Cytokines |
en_US |
dc.subject |
article |
en_US |
dc.subject |
clinical article |
en_US |
dc.subject |
gamma interferon |
en_US |
dc.subject |
interleukin 10 |
en_US |
dc.subject |
tumor necrosis factor alpha |
en_US |
dc.subject |
relapse |
en_US |
dc.subject |
Cells, Cultured |
en_US |
dc.subject |
Leukocytes, Mononuclear |
en_US |
dc.subject |
peripheral blood mononuclear cell |
en_US |
dc.subject |
Recurrence |
en_US |
dc.subject |
recurrence risk |
en_US |
dc.subject |
Brucella melitensis |
en_US |
dc.subject |
brucellosis |
en_US |
dc.subject |
Brucellosis |
en_US |
dc.subject |
Risk Assessment |
en_US |
dc.subject |
interleukin 6 |
en_US |
dc.subject |
Gene Expression Profiling |
en_US |
dc.subject |
interleukin 1beta |
en_US |
dc.subject |
interleukin 8 |
en_US |
dc.subject |
Culture Media |
en_US |
dc.subject |
Immunity, Innate |
en_US |
dc.subject |
interleukin 2 |
en_US |
dc.subject |
granulocyte macrophage colony stimulating factor |
en_US |
dc.subject |
immunoassay |
en_US |
dc.subject |
Immunoassay |
en_US |
dc.subject |
protein secretion |
en_US |
dc.subject |
toll like receptor agonist |
en_US |
dc.title |
Ex Vivo Innate Immune Cytokine Signature of Enhanced Risk of Relapsing Brucellosis |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1371/journal.pntd.0002424 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.06 |
|
dc.relation.issn |
1935-2735 |
|